Q04771 (ACVR1_HUMAN) Homo sapiens (Human)

Activin receptor type-1 UniProtKBInterProSTRINGInteractive Modelling

509 aa; Sequence (Fasta) ; 5 identical sequences: Homo sapiens: D3DPA4; Pongo abelii: A0A6D2WS17; Gorilla gorilla gorilla: G3QKB3; Nomascus leucogenys: G1QJA7; Colobus angolensis palliatus: A0A2K5I8W2

Available Structures

77 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of the ACVR1 (ALK2) kinase in complex with FKBP12 and the inhibitor E6201
6i1s
 Heteromer
P62942; 		172-499
1×E26; 7×EDO; 2×SO4;
Assess
Crystal structure of the kinase domain of type I activin receptor (ACVR1) in complex with FKBP12 an…
3h9r
 Heteromer
P62942; 		172-499
1×TAK; 5×SO4; 3×PG4;
Assess
Crystal structure of human ACVR1 (ALK2) in complex with FKBP12.6 and dorsomorphin
4c02
 Heteromer
P68106; 		178-499
8×FLC; 1×TAK; 13×EDO;
Assess
ALK2 antibody complex
7yru
 Heteromer
31-108
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010920a
5s7n
homo-2-mer201-499
4×LU8; 13×EDO; 2×DMS; 2×2AI; 7×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010949a
5s84
homo-2-mer201-499
4×LU8; 13×EDO; 1×TLA; 1×XK1; 5×SO4; 1×DMS;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010955a
5s9k
homo-2-mer201-499
4×LU8; 13×EDO; 2×DMS; 6×SO4; 1×YV4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010943a
5s7l
homo-2-mer201-499
4×LU8; 11×EDO; 2×DMS; 5×XHJ; 5×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010960a
5s8b
homo-2-mer201-499
4×LU8; 12×EDO; 2×DMS; 7×XFV; 6×SO4;
Assess
Crystal structure of the ACVR1 kinase domain in complex with LDN-193189
3q4u
homo-2-mer201-499
2×LDN; 7×EDO; 6×FLC;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074484b
5s8a
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 1×TLA; 2×XKY; 6×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010926a
5s7t
homo-2-mer202-499
4×LU8; 12×EDO; 2×DMS; 6×XGJ; 5×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010952a
5s86
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 2×XK7; 6×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010936a
5s7k
homo-2-mer202-499
4×LU8; 13×EDO; 2×XEJ; 5×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000275d
5s7m
homo-2-mer202-499
3×LU8; 12×EDO; 2×DMS; 3×HVK; 6×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000884c
5s85
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 7×XK4; 6×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with HM000007h
5s7w
homo-2-mer202-499
4×LU8; 13×EDO; 1×TAR; 2×GLY; 6×SO4; 1×DMS;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010948a
5s83
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 1×TLA; 1×XJY; 6×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010933a
5s7y
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 7×SO4; 5×XJP;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010947a
5s81
homo-2-mer202-499
4×LU8; 12×EDO; 2×DMS; 1×TLA; 6×XJV; 5×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010944a
5s7q
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 6×SO4; 2×XJM;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010938a
5s7u
homo-2-mer202-499
4×LU8; 14×EDO; 2×DMS; 6×SO4; 2×XGY;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035128c
5s82
homo-2-mer202-499
4×LU8; 13×EDO; 2×DMS; 6×SO4; 1×LAC;
Assess
Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor…
3oom
homo-2-mer203-499
4×PO4; 2×507; 30×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with an Quinazolinone based ALK2 inhibitor …
6gin
homo-2-mer204-499
2×IR2; 6×SO4; 4×EDO;
Assess
Crystal structure of the ACVR1 kinase domain in complex with the imidazo[1,2-b]pyridazine inhibitor…
4dym
homo-2-mer207-499
4×SO4; 2×IYZ; 8×GOL;
Assess
Crystal structure of the kinase domain of the Q207E mutant of ACVR1 (ALK2) in complex with a 2-amin…
6eix
monomer192-503
1×A3F; 9×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2117
6srh
monomer201-499
1×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010928a
5s7i
monomer201-499
3×LU8; 9×EDO; 1×DMS; 3×HV2; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010953a
5s87
monomer201-499
3×LU8; 9×EDO; 1×DMS; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010914a
5s7h
monomer201-499
3×LU8; 9×EDO; 1×DMS; 2×HVB; 4×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with PK012456b
5s7a
monomer201-499
3×LU8; 9×EDO; 1×DMS; 2×T5V; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000893d
5s7j
monomer201-499
3×LU8; 9×EDO; 1×XHG; 1×DMS; 2×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM007391c
5s7o
monomer201-499
3×LU8; 9×EDO; 1×TLA; 2×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010934a
5s78
monomer202-499
3×LU8; 7×EDO; 3×XGV; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010913a
5s75
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×SRT; 2×HUH; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with NU074488b
5s7z
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 2×BYZ; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010921a
5s7s
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 1×09V; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010957a
5s89
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×XKV; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000376d
5s7x
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 1×LGA; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010935a
5s7f
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035133b
5s77
monomer202-499
3×LU8; 8×EDO; 1×DMS; 1×TLA; 1×BAQ; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010954a
5s88
monomer202-499
3×LU8; 8×EDO; 1×DMS; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010923a
5s7d
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 1×XHD; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010942a
5s7v
monomer202-499
3×LU8; 9×EDO; 1×DMS; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010916a
5s76
monomer202-499
3×LU8; 7×EDO; 1×DMS; 1×TLA; 2×02A; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000274c
5s7c
monomer202-499
3×LU8; 8×EDO; 1×DMS; 3×T5Y; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010937a
5s7p
monomer202-499
3×LU8; 8×EDO; 1×DMS; 1×V1L; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM000329d
5s7b
monomer202-499
3×LU8; 8×EDO; 1×DMS; 2×XH7; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010930a
5s7e
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2118
6z36
monomer202-499
3×SO4; 1×EDO; 1×TAR; 3×Q5Z;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2009
6szm
monomer202-499
3×M2Z; 2×SO4; 5×EDO; 1×NH4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010918a
5s7r
monomer202-499
3×LU8; 7×EDO; 1×TLA; 5×XGS; 3×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010910a
5s79
monomer202-499
3×LU8; 9×EDO; 1×DMS; 2×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with FM010946a
5s80
monomer202-499
3×LU8; 9×EDO; 1×DMS; 1×TLA; 3×SO4;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazolinone based ALK2 inhibitor w…
6gi6
monomer202-499
1×EZB; 4×SO4; 10×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2304
8c7w
monomer202-499
1×U0C; 7×SO4; 4×EDO;
Assess
Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-71807
6jux
monomer203-499
1×C9U; 2×SO4;
Assess
XChem group deposition -- Crystal Structure of human ACVR1 in complex with XS035844b
5s7g
monomer202-498
3×LU8; 8×EDO; 1×DMS; 2×PPI; 3×SO4;
Assess
Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazo…
7c3g
monomer203-499
1×FH0; 9×SO4; 2×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound BI-9564
6tn8
monomer204-499
4×DIO; 1×5U6; 2×SO4; 3×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K3007
6t8n
monomer203-498
1×EDO; 1×SO4; 1×TLA; 1×MVE;
Assess
Crystal structure of human ALK2 kinase domain with R206H mutation in complex with RK-59638
6acr
monomer203-498
1×9TO; 3×SO4;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with LDN-212854
5oxg
monomer203-498
1×B4B; 2×CA;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2158
7a21
monomer203-498
1×QWQ; 1×DMS;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Momelotinib
7nns
monomer204-499
6×EDO; 1×C87; 7×SO4;
Assess
Crystal structure of the ACVR1 kinase in complex with a 2-aminopyridine inhibitor
3mtf
monomer203-498
4×PO4; 10×EDO; 1×A3F;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with a Quinazolinone based ALK2 inhibitor w…
6gip
monomer204-499
1×EUN; 4×SO4; 2×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2149
6t6d
monomer204-499
1×MM8; 3×SO4;
Assess
Crystal structure of the ACVR1 kinase in complex with LDN-213844
4bgg
monomer203-498
1×844; 3×FLC; 1×EDO;
Assess
Crystal structure of the kinase domain of ACVR1 (ALK2) with M4K2234
8r7g
monomer205-499
1×YEE;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound M4K2308
8c7z
monomer204-498
1×NH4; 1×TZX; 5×SO4; 11×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with cyclical inhibitor OD36.
5oy6
monomer204-498
1×B4E; 2×EDO;
Assess
Crystal structure of the ACVR1 (ALK2) kinase in complex with the compound Saracatinib (AZD0530)
6zgc
monomer205-499
1×H8H; 1×K; 4×PO4;
Assess
Kinase domain of ALK2-K492A/K493A with LDN-193189
6uns
monomer204-496
1×LDN;
Assess
Kinase domain of ALK2-K493A with AMPPNP
6unq
monomer206-496
1×ANP; 4×MG;
Assess
Kinase domain of ALK2-K492A/K493A with AMPPNP
6unr
monomer208-496
1×ANP; 8×MG;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6eix.1.Amonomer0.81192-503
1×A3F;99.70
Assess